Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Integrated BioPharma Inc. (INBP) had Return on Tangible Equity of -4.41% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$10.11M |
|
$-0.84M |
|
$10.38M |
|
$-0.28M |
|
$11.19M |
|
$-1.08M |
|
$0.05M |
|
$-1.03M |
|
$-1.03M |
|
$-0.84M |
|
$-0.84M |
|
$-0.84M |
|
$-0.84M |
|
$-1.08M |
|
$-0.73M |
|
31.06M |
|
31.06M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$17.97M |
|
$1.70M |
|
$8.70M |
|
$26.67M |
|
$5.53M |
|
$0.08M |
|
$2.16M |
|
$7.69M |
|
$18.98M |
|
$18.98M |
|
$18.98M |
|
31.09M |
|
| Cash Flow Statement Financials | |
$2.44M |
|
$-0.19M |
|
$-0.03M |
|
$3.62M |
|
$5.83M |
|
$2.21M |
|
$0.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.25 |
|
-- |
|
-- |
|
0.00 |
|
0.01 |
|
-2.73% |
|
-10.74% |
|
-10.74% |
|
-- |
|
-10.24% |
|
-8.28% |
|
$2.24M |
|
-- |
|
-- |
|
-- |
|
0.38 |
|
1.28 |
|
2.77 |
|
32.55 |
|
-4.41% |
|
|
Return on Tangible Equity |
-4.41% |
-3.14% |
|
-4.39% |
|
$0.61 |
|
$0.07 |
|
$0.08 |
|